One of the most important concepts in molecular biology is known as the “central dogma”, first coined by Francis Crick in 1958. Crick’s dogma accurately describes the flow of information through biological systems – from DNA sequence, to RNA, and finally to protein – that underpins cellular life as we know it.
Download the Proteomics Playbook here.
As illustrated in the central dogma each component (nucleic acids and proteins) plays an essential role in creating and maintaining cellular activity. Unsurprisingly, nucleic acids have been extensively studied to understand how changes in DNA and RNA sequences can affect biological processes. Now, thanks to dramatic innovations in next-generation sequencing technology, genomic and transcriptomic analysis can be carried out at impressive resolution, providing critical insights into how genomic variation and transcriptional defects can impact biological processes and cause disease.
For proteins, this analysis is not as simple. Unlike DNA, there is incredible diversity in the concentration and variety of proteins created by a cell at any given moment, with an estimated one million proteoforms present within humans. Additionally, the proteins produced by a cell can change dramatically according to its activity, energetic demands, stage of development, environment or external stimuli. This set of proteins – the proteome – only provides researchers with a snapshot in time, with the dynamic nature of translation and high protein instability being a common hurdle for proteomic analysis.
In this feature, we will explore the proteome, what it can tell us, and give a brief overview of some of the methods that have historically been used for proteomic analysis.
What’s in a proteome?
According to common scientific convention, a proteome is usually defined as the set of proteins produced by a cell or an organism at a certain time, under certain conditions. Often, these “conditions” refers to the specific environmental factors, physiological states, or experimental manipulations that influence protein expression within a cell or organism at the time of analysis. For many proteomics experiments, this includes variations in temperature and pH, the addition of cell stressors, the use of certain disease cell lines, or genetic manipulation to alter the expression of target proteins.
Although less common, proteome can also be used as a term for all proteins created within a sub-cellular system at a given moment – the clearest example of this being the mammalian mitochondrial proteome that consists of 1,000 – 1,500 core proteins1. Subcellular proteomics is a useful technique to understand how the localisation of proteins changes from one subcellular compartment to another, or upon cellular perturbation – bringing us the relatively new field of spatial proteomics2.
Given the proteome provides a unique window into the cause and progression of many diseases, substantial efforts have been made to identify and characterise the human proteome. Beginning in 2010, the Human Proteome Project (HPP) is an international collaborative effort aiming to catalogue and annotate the entire human proteome, encompassing the full complement of proteins expressed in various cell types, tissues and organs under different physiological conditions. As of 2023, the initiative has uncovered approximately 93%3 of the human proteome – just over 18,000 proteins – with the HPP now transitioning to research aimed at understanding the primary function of all the proteins identified.
Importantly, proteomic analysis is not limited to mammalian cells; the analysis of bacterial, fungal and viral proteomes is an essential part of disease control and therapeutic interventions worldwide4. Microbial proteomics techniques enable the identification, quantification and functional characterisation of microbial proteins, shedding light on their diversity, expression patterns, post-translational modifications and interactions with host organisms or environmental factors. This exploration uncovers pivotal mechanisms in microbial physiology, pathogenesis, antibiotic resistance and symbiotic relationships, driving the development of novel therapies and vaccines.
Decoding the proteome: an overview of proteomic techniques
Considering the prominence of proteomic analysis in molecular biology, a wide variety of methodologies have emerged to explore the intricacies of protein structure and dynamics. These approaches can be broadly categorised into two main groups: those reliant on mass spectrometry (including bottom-up, top-down, quantitative, and structural proteomics) and those that do not primarily utilise mass spectrometry (such as gel-based techniques, protein microarrays, and fluorescence-based imaging).
MASS-SPECTROMETRY-BASED METHODS
Mass spectrometry (MS) has evolved significantly since its inception in the late 19th century, with key advancements shaping its transformation into a versatile analytical tool. Originating from the work of scientists like J.J. Thomson and Francis Aston in the late 1800s5, MS found early applications in isotope analysis during World War II. Postwar developments in vacuum technology, ionization methods and instrumentation propelled its growth, leading to the emergence of tandem-MS6 (often referred to as MS/MS) in the 1960s. The advent of soft ionization techniques like electrospray ionization and matrix-assisted laser desorption/ionization in the 1980s revolutionised MS, enabling the analysis of biomolecules such as proteins and nucleic acids.
In the modern era, MS techniques continue to advance rapidly, with improvements in resolution and sensitivity driving its widespread applications in proteomics, metabolomics and the life sciences at large. At the heart of proteomic exploration, MS assumes a pivotal position, serving as the foundation for two fundamental methodologies: bottom-up and top-down proteomics.
NON-MASS SPECTROMETRY-BASED METHODS
There are many other techniques that do not primarily rely on MS, although they may be used in conjunction with MS technology to produce the desired results. Many of these methods can be considered “affinity proteomics”, which rely on the use of antibodies and other ligands that bind to the protein of interest. Such techniques have been in circulation for decades, including lab staples such as immunoprecipitation, Western blotting and affinity chromatography. These classical techniques are valuable in the purification and identification of target proteins7, although researchers may prefer to use more advanced methods for protein quantification and characterisation.
Additionally, the upstream separation of complex protein mixtures often requires gel-based techniques, including Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), two-dimensional gel electrophoresis (2-DE) and two-dimensional differential gel electrophoresis (2D-DIGE) techniques. As a cornerstone of proteomics research, these methods are often required when preparing samples for downstream analysis, including MS-based techniques8. Although we recognise the vital role of the aforementioned techniques in driving proteomics research forwards, we refer readers to other sources highlighting recent advancements in gel-based protein separation methods7,9.
One preferred method for protein characterisation is the use of protein microarrays, a high-throughput screening platform that consists of an array of immobilised proteins. These microarrays enable the simultaneous analysis of thousands of proteins, making them powerful tools for studying protein-protein interactions, protein-ligand interactions and protein-drug interactions in a massively parallel manner. Protein microarrays offer several advantages over traditional biochemical assays, including their high throughput, low sample consumption and the ability to study multiple interactions simultaneously10.
Another example of a high-throughput proteomics technique is protein sequencing, which can be done via Edman degradation, MS or next-generation sequencing methods. Protein sequencing has emerged as a powerful tool for determining the precise amino acid sequence of proteins – essential for understanding their structure, function and post-translational modifications. To discover the latest high-throughput proteomics research and market updates, download the Proteomics Playbook here.
References
Baker, Z. N., Forny, P. & Pagliarini, D. J. Mitochondrial proteome research: the road ahead. Nat. Rev. Mol. Cell Biol. 25, 65–82 (2024).
Lundberg, E. & Borner, G. H. H. Spatial proteomics: a powerful discovery tool for cell biology. Nat. Rev. Mol. Cell Biol. 20, 285–302 (2019).
Omenn, G. S. et al. The 2023 Report on the proteome from the HUPO Human Proteome Project. J. Proteome Res. 23, 532–549 (2024).
Kathera, C. Microbial proteomics and their importance in medical microbiology. Recent Developments in Applied Microbiology and Biochemistry 21 (2019).
Griffiths, J. A brief history of mass spectrometry. Anal. Chem. 80, 5678–5683 (2008).
McLafferty, F. W. Tandem mass spectrometry. Science 214, 280–287 (1981).
Sample preparation for mass spectrometry – UK. Thermo Fisher Scientific https://www.thermofisher.com/uk/en/home/life-science/ protein-biology/protein-biology-learning-center/protein-biologyresource-library/pierce-protein-methods/sample-preparationmass-spectrometry.html.
Aslam, B., Basit, M., Nisar, M. A., Khurshid, M. & Rasool, M. H. Proteomics: Technologies and their applications. J. Chromatogr. Sci. 55, 182–196 (2017).Guo, Y., Cupp-Sutton, K. A., Zhao, Z., Anjum, S. & Wu, S. Multidimensional separations in top-down proteomics. Anal Sci Adv 4, 181–203 (2023).
Syu, G.-D., Dunn, J. & Zhu, H. Developments and applications of functional protein microarrays. Mol. Cell. Proteomics 19, 916–927 (2020).




